Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Depreciation & Amortization (CF) (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $21261.0 as the latest value for Q4 2021.

  • Quarterly Depreciation & Amortization (CF) fell 60.79% to $21261.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $116238.0 through Dec 2021, up 17.01% year-over-year, with the annual reading at $44045.0 for FY2025, 5.26% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2021 was $21261.0 at ENDRA Life Sciences, down from $29823.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $54228.0 in Q4 2020, with the low at $1100.0 in Q3 2020.
  • Average Depreciation & Amortization (CF) over 5 years is $21297.7, with a median of $19999.5 recorded in 2018.
  • The sharpest move saw Depreciation & Amortization (CF) crashed 94.48% in 2020, then surged 2611.18% in 2021.
  • Over 5 years, Depreciation & Amortization (CF) stood at $15360.0 in 2017, then soared by 30.66% to $20070.0 in 2018, then increased by 4.16% to $20904.0 in 2019, then surged by 159.41% to $54228.0 in 2020, then plummeted by 60.79% to $21261.0 in 2021.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $21261.0, $29823.0, and $33729.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.